Moderna downsizing investments in late-stage vaccine trials amid U.S. skepticism

Pharmaceutical company Moderna says it is scaling down its investments in late-stage vaccine trials amid growing opposition to immunizations from U.S. officials. CBS News medical contributor Dr. Céline Gounder breaks it down.